EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment

Xuemei Huang iD, Jiajin Jiang, Li Liu, Yuanyuan Lin, Feng Zhang, Xiaoshan Ling, Haitao Wei, Guangjing Huang, Jinqun Ye, Cen Huang, Jianli Huang, Wenfu Tao und 1 weitere

Journal of Diabetes Investigation · 2025-03 · 16 (3) · 426-433

DOI: 10.1111/jdi.14371 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 28.11.2024. Verfasst von Xuemei Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First People's Hospital of Nanning, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin, Hypoglycemic Agents, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanning Qingxiu District Science and Technology Plan Project, Research and Cultivation Project of First People's Hospital of Nanning, Health Self-financing Research Projects of Guangxi Zhuang Autonomous Region of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim/Introduction To evaluate the therapeutic efficacy short‐term continuous subcutaneous insulin infusion (CSII) intensive therapy combined with a low‐carbohydrate diet (LCD) for diabetes remission in patients with newly diagnosed type 2 diabetes mellitus. Materials and Methods This study included patients newly diagnosed with type 2 diabetes mellitus, who were randomly divided into two groups: conventional (conventional CSII + traditional lifestyle guidance); and intensive (intensive CSII + LCD lifestyle guidance). CSII was used for blood glucose control, with continuous glucose monitoring (CGM) used to monitor blood glucose levels. The primary outcome measure was hemoglobin A1c (HbA1c) level; secondary outcomes included body weight, body mass index (BMI), waist circumference, glycemic control, and biochemical indices.

Results

The time in range (TIR) in the intensive treatment group was greater than that in the conventional treatment group ( P < 0.05). There was no significant difference in the incidence of hypoglycemia between the two groups ( P > 0.05). Compared with the conventional treatment group, diabetes remission rates were significantly greater in the intensive treatment group ( P < 0.05). In the intensive treatment group, fasting plasma glucose (FPG), HbA1c, Homeostasis Model assessment of Insulin Resistance (HOMA‐IR), triglycerides (TG), low‐density lipoprotein cholesterol (LDL‐c), and changes in body weight, BMI, visceral fat area (VFA), and subcutaneous fat area (SFA) decreased significantly ( P < 0.05). FPG, HOMA‐IR, TG, LDL‐c, and changes in body weight, BMI, waist circumference, and VFA were significantly correlated with HbA1c levels ( P < 0.05).

Conclusions

The combination of intensive CSII and LCD lifestyle guidance had been improved the remission rate in patients with newly diagnosed type 2 diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2InsulinHypoglycemic AgentsDiet, Carbohydrate-RestrictedInsulin Infusion SystemsHumansMaleFemaleMiddle AgedBlood GlucoseGlycated HemoglobinInfusions, SubcutaneousRemission InductionAdultAgedCombined Modality TherapyTreatment OutcomePrognosisBiomarkers

Stichwörter der Autor:innen

Continuous subcutaneous insulin infusionDiabetes remissionLow‐carbohydrate diet

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, The First People's Hospital of Nanning, Nanning, Guangxi, China.
  • Department of Clinical Laboratory, The First People's Hospital of Nanning, Nanning, Guangxi, China.
  • Department of Nutrition, The First People's Hospital of Nanning, Nanning, Guangxi, China.

ORCID-Profile: Xuemei Huang

Förderung

  • Nanning Qingxiu District Science and Technology Plan Project
  • Research and Cultivation Project of First People's Hospital of Nanning
  • Health Self-financing Research Projects of Guangxi Zhuang Autonomous Region of China

Zitieren

APA

Huang, X., Jiang, J., Liu, L., Lin, Y., Zhang, F., Ling, X., Wei, H., Huang, G., Ye, J., Huang, C., Huang, J., Tao, W., & Zou, X. (2025). Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment. Journal of Diabetes Investigation, 16(3), 426-433. https://doi.org/10.1111/jdi.14371

Vancouver

Huang X, Jiang J, Liu L, Lin Y, Zhang F, Ling X, et al. Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment. Journal of Diabetes Investigation. 2025;16(3):426-433. doi:10.1111/jdi.14371

BibTeX
@article{Huang2025,
  author = {Huang, Xuemei and Jiang, Jiajin and Liu, Li and Lin, Yuanyuan and Zhang, Feng and Ling, Xiaoshan and Wei, Haitao and Huang, Guangjing and Ye, Jinqun and Huang, Cen and Huang, Jianli and Tao, Wenfu and Zou, Xinyu},
  title = {Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {426--433},
  doi = {10.1111/jdi.14371}
}
Kostenlos starten →